Search Results - "Hilder, B. W"

S182: TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED EFFICACY AND SAFETY RESULTS FROM MONUMENTAL‐1 by Minnema, M. C., Krishnan, A., Berdeja, J. G., Oriol, A., Donk, N. W., Rodríguez‐Otero, P., Morillo, D., Mateos, M.‐V., Costa, L. J., Caers, J., Vishwamitra, D., Ma, J., Yang, S., Hilder, B. W., Tolbert, J., Goldberg, J. D., Chari, A.

Get full text

P10: TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED PHASE 1 RESULTS FROM MONUMENTAL‐1 by Donk, N. W. C. J, Minnema, M C, Berdeja, J G, Oriol, A, Krishnan, A, Rodríguez‐Otero, P, Askari, E, Mateos, M, Costa, L. J, Verona, R, Ma, J, Girgis, S, Yang, S, Hilder, B. W, Russell, J, Goldberg, J. D, Chari, A

Get full text

A Phase 1 and 2 study of Filanesib alone and in combination with low‐dose dexamethasone in relapsed/refractory multiple myeloma by Shah, Jatin J., Kaufman, Jonathan L., Zonder, Jeffrey A., Cohen, Adam D., Bensinger, William I., Hilder, Brandi W., Rush, Selena A., Walker, Duncan H., Tunquist, Brian J., Litwiler, Kevin S., Ptaszynski, Mieke, Orlowski, Robert Z., Lonial, Sagar

“…BACKGROUND Filanesib (ARRY‐520) is a highly selective inhibitor of kinesin spindle protein, which has demonstrated preclinical antimyeloma activity. METHODS…”
Get full text